D4875

16-Dehydropregnenolonacetat

≥95%

• Synonym(e): 3β-Acetoxy-5,16-pregnadien-20-one, 3β-Hydroxy-5,16-pregnadien-20-one acetate, 5,16-Pregnadien-3β-ol-20-one acetate
• Empirische Formel (Hill-System): C₂₃H₃₂O₃
• CAS-Nummer: 979-02-2
• Molekulargewicht: 356.50
• EG-Nummer: 213-558-7
• MDL-Nummer: MFCD00051130
• UNSPSC-Code: 12352202
• PubChem Substanz-ID: 24893901
• NACRES: NA.77

Eigenschaften

• Assay: ≥95%
• Form: powder
• SMILES String: CC(=O)OC1CCC2(C)C3CCC4(C)C(CC=C4C(C)=O)C3CC=C2C1
• InChI: 1S/C23H32O3/c1-14(24)19-7-8-20-18-6-5-16-13-17(26-15(2)25)9-11-22(16,3)21(18)10-12-23(19,20)4/h5,7,17-18,20-21H,6,8-13H2,1-4H3
• InChIKey: MZWRIOUCMXPLKV-UHFFFAOYSA-N

Beschreibung

Biochem./physiol. Wirkung

16-Dehydropregnenolone acetate (DPA) is synthesized from steroids sapogenin, diosgenin and solasodine. 16-Dehydropregnenolone acetate (DPA) is a crucial intermediate for the synthesis of steroid hormones-based drugs. It is an antagonist for farnesoid X receptor (FXR) and modulates cholesterol metabolism. It is considered as a potential antihyperlipidemic agent. Chemically synthesized steroid derivatives from DPA have cytotoxic features and could serve as potential anticancer agents.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)